BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1366138)

  • 1. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
    Vlak T; Jajić Z
    Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of Na-aurothiomalate on circulating immune complex dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):1-5. PubMed ID: 1366145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of 6 months of treatment with Tauredon on clinical indicators in rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):27-31. PubMed ID: 1366142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of rheumatoid arthritis with leukopenia to gold salts.
    Gowans JD; Salami M
    N Engl J Med; 1973 May; 288(19):1007-8. PubMed ID: 4633144
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
    Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
    Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
    [No Abstract]   [Full Text] [Related]  

  • 10. Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis.
    Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N
    J Rheumatol; 1982; 9(6):932-4. PubMed ID: 6819360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
    An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of gold salts in the treatment of rheumatoid arthritis in a group of our patients].
    Vitaus M; Androić S; Car A
    Reumatizam; 1977; 24(5):161-3. PubMed ID: 412242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parenteral gold therapy (Tauredon) in chronic polyarthritis].
    Tausch G; Gaismayer K
    Wien Klin Wochenschr Suppl; 1984; 156():19-21. PubMed ID: 6442051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.
    Lewandowicz J; Dabkowska B; Nowak D
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):195-8. PubMed ID: 8744695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phagocytic activity in rheumatoid arthritis].
    Jelcić A; Car A; Gnjidić Z; Sabioncello A
    Reumatizam; 1992; 39(2):17-9. PubMed ID: 1366147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis.
    Taukumova LA; Mouravjoy YuV ; Gribakin SG
    Adv Exp Med Biol; 1999; 455():367-73. PubMed ID: 10599371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis.
    Kadir N; Grayson MF; Campbell ED
    Ann Clin Res; 1983; 15(1):4-9. PubMed ID: 6134490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
    Rudge SR; Pound JD; Bossingham DH; Powell RJ
    J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.